{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:52:12Z","timestamp":1788364332451,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijbiomac.2025.140436","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:52:47Z","timestamp":1738065167000},"page":"140436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Discovery of pyrazoline analogs as multi-targeting cholinesterase, \u03b2-secretase and A\u03b2 aggregation inhibitors through lead optimization strategy"],"prefix":"10.1016","volume":"301","author":[{"given":"Nilesh Gajanan","family":"Bajad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Jangra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajendra","family":"T. A.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairam","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ijbiomac.2025.140436_bb0005","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1021\/acschemneuro.3c00304","article-title":"Recent advances in the development of near-infrared fluorescent probes for the in vivo brain imaging of amyloid-\u03b2 species in Alzheimer\u2019s disease","volume":"14","author":"Bajad","year":"2023","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101819","article-title":"Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer\u2019s disease: relevance for precision medicine in neurodegenerative diseases","volume":"84","author":"Lista","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140436_bb0015","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acschemneuro.8b00391","article-title":"Reconsideration of anticholinesterase therapeutic strategies against Alzheimer\u2019s disease","volume":"10","author":"Wang","year":"2018","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2018.02.035","article-title":"Secretase inhibitors for the treatment of Alzheimer\u2019s disease: long road ahead","volume":"148","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140436_bb0025","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/biomedicines9121910","article-title":"Current understanding of the physiopathology, diagnosis and therapeutic approach to Alzheimer\u2019s disease","volume":"9","author":"Garc\u00eda-Morales","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2019.05.020","article-title":"Multi-target design strategies for the improved treatment of Alzheimer\u2019s disease","volume":"176","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107082","article-title":"Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer\u2019s disease","volume":"143","author":"Bajad","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"43","key":"10.1016\/j.ijbiomac.2025.140436_bb0040","doi-asserted-by":"crossref","first-page":"38207","DOI":"10.1021\/acsomega.2c05339","article-title":"Pyrazoline containing compounds as therapeutic targets for neurodegenerative disorders","volume":"7","author":"Ahsan","year":"2022","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.140436_bb0045","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1039\/C9MD00030E","article-title":"Synthesis, molecular docking, and biological evaluation of novel 2-pyrazoline derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"10","author":"Unsal-Tan","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103080","article-title":"Development of pyrazole and spiropyrazoline analogs as multifunctional agents for treatment of Alzheimer\u2019s disease","volume":"90","author":"Gutti","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0055","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ijbiomac.2020.09.043","article-title":"Thiazolyl-pyrazoline derivatives: in vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors","volume":"163","author":"Sever","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bioorg.2018.12.028","article-title":"Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity","volume":"84","author":"Ozgun","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0065","doi-asserted-by":"crossref","unstructured":"Alt\u0131ntop MD, Sa\u011fl\u0131k \u00d6zkan BmN, \u00d6zdemir A. Design, Synthesis, and evaluation of new Pyrazolines as small molecule inhibitors of acetylcholinesterase. ACS omega. 2024;9(29):31401\u20139.","DOI":"10.1021\/acsomega.3c10490"},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134137","article-title":"Design, synthesis, DFT, molecular docking, and biological evaluation of pyrazole derivatives as potent acetyl cholinestrease inhibitors","volume":"1271","author":"Abdelwahab","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.140436_bb0075","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1021\/acs.jmedchem.5b01979","article-title":"Development and in vitro evaluation of a microbicide gel formulation for a novel non-nucleoside reverse transcriptase inhibitor belonging to the N-dihydroalkyloxybenzyloxopyrimidines (N-DABOs) family","volume":"59","author":"Tintori","year":"2016","journal-title":"J. Med. Chem."},{"issue":"45","key":"10.1016\/j.ijbiomac.2025.140436_bb0080","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1002\/slct.202103779","article-title":"An overview on synthesis and biological activity of chalcone derived pyrazolines","volume":"6","author":"Tiwari","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2018.02.078","article-title":"Development of Piperazinediones as dual inhibitor for treatment of Alzheimer\u2019s disease","volume":"150","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.140436_bb0090","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1021\/jm060230+","article-title":"Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability","volume":"49","author":"Ottaviani","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111613","article-title":"Discovery of novel series of 2-substituted benzo [d] oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer\u2019s disease","volume":"182","author":"Gutti","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejmech.2019.02.030","article-title":"Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer\u2019s disease","volume":"167","author":"Sharma","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.140436_bb0105","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/cn400051e","article-title":"Tanshinones inhibit amyloid aggregation by amyloid-\u03b2 peptide, disaggregate amyloid fibrils, and protect cultured cells","volume":"4","author":"Wang","year":"2013","journal-title":"ACS Chem. Nerosci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140436_bb0110","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s11030-022-10504-7","article-title":"Combined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimer\u2019s disease","volume":"26","author":"Swetha","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0115","article-title":"Identification of novel potential cathepsin-B inhibitors through pharmacophore-based virtual screening, molecular docking, and dynamics simulation studies for the treatment of Alzheimer\u2019s disease","volume":"1-21","author":"Jangra","year":"2024","journal-title":"Mol. Divers."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140436_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/08927022.2019.1682572","article-title":"Structure-based screening and molecular dynamics simulation studies for the identification of potential acetylcholinesterase inhibitors","volume":"46","author":"Ganeshpurkar","year":"2020","journal-title":"Mol. Simul."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.140436_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115470","article-title":"Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer\u2019s disease: radical scavenging, myeloperoxidase\/acetylcholinesterase inhibition and biometal chelation","volume":"28","author":"Santos","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijbiomac.2022.01.136","article-title":"Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach","volume":"203","author":"Ganeshpurkar","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140436_bb0135","doi-asserted-by":"crossref","first-page":"14778","DOI":"10.1038\/s41598-023-41941-5","article-title":"Enantioseparation and molecular docking study of selected chiral pharmaceuticals on a commercialized phenylcarbamate-\u03b2-cyclodextrin column using polar organic mode","volume":"13","author":"Dob\u00f3","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140436_bb0140","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/molecules28031084","article-title":"A review on recent approaches on molecular docking studies of novel compounds targeting acetylcholinesterase in Alzheimer disease","volume":"28","author":"Peitzika","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2012.12.010","article-title":"Elucidating the catalytic mechanism of \u03b2-secretase (BACE1): a quantum mechanics\/molecular mechanics (QM\/MM) approach","volume":"40","author":"Barman","year":"2013","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02253713","article-title":"Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock","volume":"101","author":"Itoh","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0155","doi-asserted-by":"crossref","unstructured":"Hli\u0148\u00e1k Z, Krej\u010d\u0131\u0301 I. Concurrent administration of subeffective doses of scopolamine and MK-801 produces a short-term amnesia for the elevated plus-maze in mice. Behav. Brain Res. 1998;91(1\u20132):83\u20139.","DOI":"10.1016\/S0166-4328(97)00107-1"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140436_bb0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140436_bb0165","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1021\/acs.jmedchem.6b00426","article-title":"Benzylpiperidine-linked diarylthiazoles as potential anti-Alzheimer\u2019s agents: synthesis and biological evaluation","volume":"59","author":"Shidore","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112257","article-title":"Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer\u2019s disease","volume":"198","author":"Singh","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0175","doi-asserted-by":"crossref","first-page":"10979","DOI":"10.1039\/D4NJ01462F","article-title":"Novel asymmetric biscarbothioamides as Alzheimer\u2019s disease associated cholinesterase inhibitors: synthesis, biological activity, and molecular docking studies","volume":"48","author":"Mu\u011flu","year":"2024","journal-title":"New J. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.140436_bb0180","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nprot.2010.72","article-title":"Preparation and characterization of toxic A\u03b2 aggregates for structural and functional studies in Alzheimer\u2019s disease research","volume":"5","author":"Jan","year":"2010","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140436_bb0185","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bmcl.2007.12.028","article-title":"Potent memapsin 2 (\u03b2-secretase) inhibitors: design, synthesis, protein-ligand X-ray structure, and in vivo evaluation","volume":"18","author":"Ghosh","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140436_bb0190","doi-asserted-by":"crossref","first-page":"2100294","DOI":"10.1002\/ardp.202100294","article-title":"Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds","volume":"354","author":"Sever","year":"2021","journal-title":"Arch. Pharm."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140436_bb0195","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1080\/07391102.2023.2240889","article-title":"Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions","volume":"42","author":"G\u00fcle\u00e7","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.140436_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125558","article-title":"Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase","volume":"410","author":"G\u00fcle\u00e7","year":"2024","journal-title":"J. Mol. Liq."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140436_bb0205","doi-asserted-by":"crossref","first-page":"34984","DOI":"10.1038\/srep34984","article-title":"Structural insights into conformational stability of both wild-type and mutant EZH2 receptor","volume":"6","author":"Aier","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140436_bb0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/pr9010071","article-title":"Molecular dynamics simulations in drug discovery and pharmaceutical development","volume":"9","author":"Salo-Ahen","year":"2020","journal-title":"Processes"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.140436_bb0215","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.bmc.2013.06.003","article-title":"Synthesis, evaluation and molecular dynamics study of some new 4-aminopyridine semicarbazones as an antiamnesic and cognition enhancing agents","volume":"21","author":"Sinha","year":"2013","journal-title":"Bioorg. Med. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025009857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025009857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:08:18Z","timestamp":1782900498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025009857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":43,"alternative-id":["S0141813025009857"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140436","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of pyrazoline analogs as multi-targeting cholinesterase, \u03b2-secretase and A\u03b2 aggregation inhibitors through lead optimization strategy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"140436"}}